Maryland Life Sciences
Maryland at BIO
Get to Know Maryland.
Maryland has its very own ecosystem of life sciences companies, making the state an impressive hub for scientific innovation. Maryland's life sciences industry not only stands out among other states, but also shines internationally. Our team, along with a delegation of Maryland companies, will represent Maryland at the BIO International Convention on June 3-6. Visit the Commerce team at Booth No. ____ to see what Maryland offers businesses. Below, you can learn more about the leaders behind some life sciences companies that proudly call Maryland home and find their direct contact info for those interested in partnering.
The Maryland Delegation
COMPANIES EXHIBITING AT BIO INTERNATIONAL
These companies are exhibiting in the Maryland pavilion at the BIO International Convention. Scroll below for full company profiles.
Discovering and developing innovative therapies to improve the lives of millions affected by neurological disorders like Alzheimer’s disease.
Sonogen Medical is working to commercialize a next-generation ultrasonic bone fracture healing device, with built-in diagnostic fracture healing capability.
Provides surgical confidence in the operating room, making critical anatomy visible by providing structural and functional tissue information to operating surgeons in real-time to improve patient health.
Discovering and developing innovative therapies to improve the lives of millions affected by neurological disorders like Alzheimer’s disease.
Sonogen Medical is working to commercialize a next-generation ultrasonic bone fracture healing device, with built-in diagnostic fracture healing capability.
Provides surgical confidence in the operating room, making critical anatomy visible by providing structural and functional tissue information to operating surgeons in real-time to improve patient health.
#3
Technology and science workforce
#1
Federal obligations for R&D
2x
Federal labs than any other state
#5
Highest concentration doctoral scientists and engineers.
Nanocrine, Inc.
Nanocrine is developing a new imaging technology that opens an entirely new domain for exploring cell biology and identifying molecular targets for drug development.
The company's key technology, named Nanoplasmonic Imaging, enables real-time, label-free, quantitative analysis of the extracellular environment during live-cell imaging.
Contact:
Patrick Calhoun, President & Chief Science Officer
Kubanda Cryotherapy Inc.
Kubanda is a cryotherapy company brining minimally invasive tumor treatment to traditionally underserved markets.
The company's beachhead market is veterinary medicine. A premium procedure that’s simpler than surgery, with cryotherapy, clinics can charge less while making more and providing higher level care.
Contact:
Bailey Surtees, CEO
Fzata, Inc.
Fzata is an NIH-SEED company in drug development. The company leverages its yeast platform to develop first-in-class, oral, live yeast synthetic biologic drugs. Yeast acts as a “factory” making drug on-site in the GI.
Fzata is is located at bwtech@UMBC, employing 10 FTE with four fully equipped labs and offices. Yeast platform and asset patents are granted and pending in US and PCT.
Contact:
Elizabeth Smith, Chief Business Officer
LASARRUS
LASARRUS improves the quality of care for patients with Chronic Obstructive Pulmonary Disease (COPD) and their providers with its innovative, device-enabled solution.
Contact:
Dr. Lloyd Emokpae, CEO
Optosurgical, LLC.
Optosurgical, LLC is an early-stage startup that specializes in the research and development (R&D) of intraoperative imaging technologies and holds technical expertise in biomedical optics, surgical vision, and stakeholder/clinical validations.
Their mission is to improve health outcomes by researching, developing, and licensing new intraoperative imaging technologies.
Contact:
Yoseph Kim, CEO
Previse
Previse is a gastrointestinal health company that provides precision medicine solutions to guide patient care, initially focused on upper GI conditions such as GERD and esophageal precancer.
Contact:
Daniel Lunz, CEO
WearableDose
WearableDose revolutionizes cancer treatment with its AI-guided precision dosimetry, enhancing radiation therapy accuracy and patient outcomes.
Contact:
John Sanwo, Founder
Sonogen Medical, Inc.
Sonogen Medical, Inc. is a medical technology company, working to commercialize a next-generation bone fracture healing device based on its patent-pending acoustic shear wave technology.
Contact:
Jason Winder, CEO
Solaxa Inc.
Solaxa Inc. is clinical-ready, pharmaceutical company developing therapies to restore nerve function.
Contact:
Christian Walker, CEO & Founder
MelaTech
MelaTech Biomanufacturing melanin and R&D of melanin-based biotechnologies.
Contact:
Dr. Radamés J.B. Cordero, CEO & Co-Founder
Veralox Therapeutics
.Veralox Therapeutics is a startup biotech focused on developing treatment for serious immune mediated diseases
Contact:
Lisa Beck, Chief Business Officer
Neuroene Therapeutics
Neuroene Therapeutics is a small biotech startup developing mitochondrial therapeutics for difficult to treat neurological diseases.
Contact:
Dr. Sherine Chan, Co-Founder & CEO
Silvec Biologics Inc.
Silvec Biologics Inc. is an agricultural biotechnology company that is developing RNA therapies for trees.
Contact:
Rafael Simon, CEO
Auxergen Inc.
Auxergen Inc. focus on agricultural biocontrol of plant pathogens, novel anti-microbe agents, bacteriophages.
Contact:
Dr. Ting-Yi Yeh, Co-Founder & Chief Science Officer
IGC Pharma inc.
IGC Pharma inc. is a small clinical stage pharmaceutical company engaged in Alzheimer's research. Their lead formulation is in a Phase 2b trial on agitation in dementia from Alzheimer's.
Contact:
Ram Mukunda, CEO